Separation & Purification

GEA spoke to Biopharma-Reporter at the Nuremberg Conference Centre yesterday

DISPATCHES FOM TECHNOPHARM, NUREMBERG

MAb production driving continuous fermentation, says GEA

By Dan Stanton

Development of continuous fermentation has been driven by the increased production of monoclonal antibodies says GEA, with Asia-Pacific the new growth driver for such technologies.

Green chemistry yet to attract drug industry

Pre CPhI Special

How green was my Valium? Not very, despite industry claims

By Gareth Macdonald

Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to believe claims drug industry 'demand' will create a $100bn market for environmentally-friendly production methods by 2020.

Follow us

Product Innovations